4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-24-000811
Chief Financial Officer acquired 590,413 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Alam Kamran · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-02 | Grant or award : show line 1 in the form | +590,413 | 842,225 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-02 | Grant or award : show line 2 in the form Employee Stock Option (right to buy) | +590,413 | 590,413 | D |
Loading xslF345X05/doc4.xml…